US FDA Could Require Pediatric Cancer Drug Combo Studies Under Amended User Fee Bill

Pediatric cancer
Pediatric studies of investigational cancer drug combinations could be required by FDA under amended user fee bill • Source: Shutterstock

More from Clinical Trials

More from R&D